Quest Diagnostics
This article was originally published in The Gray Sheet
Executive Summary
Whistleblower lawsuit leads to $11.4 mil. payment to settle charges that the firm billed Medicare for unnecessary apolipoprotein tests when doctors ordered other blood tests for cardiac risk evaluation, according to Washington D.C. law firm Phillips & Cohen, which represents the whistleblower. The "qui tam" suit alleging billing fraud from 1990 to 1997 was filed in 1997 by Kevin Spear, a salesman for Unilab, which Quest acquired in 2002...